Literature DB >> 10718326

Sleep in the Wistar-Kyoto rat, a putative genetic animal model for depression.

C Dugovic1, L C Solberg, E Redei, O Van Reeth, F W Turek.   

Abstract

The Wistar-Kyoto (WKY) rat exhibits several behavioral and hormonal abnormalities often associated with depression. One of the hallmarks of depression consists of alterations in the sleep-wake cycle, particularly in rapid eye movement (REM) sleep. If the WKY rat is indeed an animal model for depression, we hypothesized that it should also show sleep abnormalities relative to the control strain, the Wistar (WIS) rat Under baseline conditions, WKY rats showed a 50% increase in total REM sleep time during the 12 h light phase and an increase in sleep fragmentation during both the light and dark phase. The WKY rats also exhibited lower EEG power densities over the entire frequency range (0.2-25.0 Hz) during REM sleep. After a 6 h sleep deprivation, the REM sleep rebound was more pronounced during the dark but not the light phase in the WKY rats. Since the WKY rat represents a genetic model for depression with altered EEG sleep patterns, this strain may be particularly useful for investigating the relationship between depression and sleep abnormalities.

Entities:  

Mesh:

Year:  2000        PMID: 10718326     DOI: 10.1097/00001756-200002280-00038

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  31 in total

1.  TASK-3 as a potential antidepressant target.

Authors:  Anthony L Gotter; Vincent P Santarelli; Scott M Doran; Pamela L Tannenbaum; Richard L Kraus; Thomas W Rosahl; Hamid Meziane; Marina Montial; Duane R Reiss; Keith Wessner; Alexander McCampbell; Joanne Stevens; Joseph I Brunner; Steven V Fox; Victor N Uebele; Douglas A Bayliss; Christopher J Winrow; John J Renger
Journal:  Brain Res       Date:  2011-08-16       Impact factor: 3.252

Review 2.  Role of orexin in central regulation of gastrointestinal functions.

Authors:  Toshikatsu Okumura; Kaoru Takakusaki
Journal:  J Gastroenterol       Date:  2008-09-20       Impact factor: 7.527

3.  Heterogeneous stock rats: a model to study the genetics of despair-like behavior in adolescence.

Authors:  K Holl; H He; M Wedemeyer; L Clopton; S Wert; J K Meckes; R Cheng; A Kastner; A A Palmer; E E Redei; L C Solberg Woods
Journal:  Genes Brain Behav       Date:  2017-09-26       Impact factor: 3.449

4.  Antidepressant-like effects of buprenorphine in rats are strain dependent.

Authors:  Caroline A Browne; Duncan S van Nest; Irwin Lucki
Journal:  Behav Brain Res       Date:  2014-10-18       Impact factor: 3.332

5.  Fear conditioning fragments REM sleep in stress-sensitive Wistar-Kyoto, but not Wistar, rats.

Authors:  Jamie K DaSilva; Yanlin Lei; Vibha Madan; Graziella L Mann; Richard J Ross; Shanaz Tejani-Butt; Adrian R Morrison
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2010-09-09       Impact factor: 5.067

6.  N-methyl-d-aspartic acid receptors are altered by stress and alcohol in Wistar-Kyoto rat brain.

Authors:  Y Lei; S M Tejani-Butt
Journal:  Neuroscience       Date:  2010-05-11       Impact factor: 3.590

7.  High novelty-seeking rats are resilient to negative physiological effects of the early life stress.

Authors:  Sarah M Clinton; Stanley J Watson; Huda Akil
Journal:  Stress       Date:  2013-11-06       Impact factor: 3.493

8.  Effects of rapid eye movement sleep deprivation on hypocretin neurons in the hypothalamus of a rat model of depression.

Authors:  Joanne S Allard; Yousef Tizabi; James P Shaffery; Kebreten Manaye
Journal:  Neuropeptides       Date:  2007-06-27       Impact factor: 3.286

9.  Involvement of brain dopaminergic systems in the development of an MPTP-induced depressive state in rats.

Authors:  N B Pankova; N A Krupina; I N Orlova; N N Khlebnikova; G N Kryzhanovskii
Journal:  Neurosci Behav Physiol       Date:  2008-05

10.  Conditional corticotropin-releasing hormone overexpression in the mouse forebrain enhances rapid eye movement sleep.

Authors:  M Kimura; P Müller-Preuss; A Lu; E Wiesner; C Flachskamm; W Wurst; F Holsboer; J M Deussing
Journal:  Mol Psychiatry       Date:  2009-05-19       Impact factor: 15.992

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.